SEMA3C regulates the autophagy process and enhances the tumor immunosuppressive related genes expression of macrophage, thus targeting the SEMA3C is a promising target in pancreatic cancer therapy. The gene discussed is SEMA3C; the disease is familial pancreatic carcinoma.